INMB

INMB

USD

INmune Bio Inc. Common stock

$1.720-0.050 (-2.825%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.770

Hoch

$1.790

Tief

$1.710

Volumen

0.26M

Unternehmensfundamentaldaten

Marktkapitalisierung

45.7M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.61M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.71Aktuell $1.720Hoch $11.64

Ähnliche Nachrichten

GlobeNewswire

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's innate

Mehr anzeigen
GlobeNewswire

INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025

Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Oct. 23, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), INmune Bio Inc. (NASDAQ:INMB), a

Mehr anzeigen
GlobeNewswire

INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025

Boca Raton, FL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB), a clinical-stage inflammation and immunology company, today announces that David Moss, Chief Executive Officer will participate in a

Mehr anzeigen
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025